We thus analyzed p16 expression in more than 15,000 tumor tissue samples from 124 different tumor types and subtypes as well as 76 non-neoplastic tissue types by immunohistochemistry in a tissue microarray (TMA) format. Here, CDKN2A is linked to neoplasm.